Search Results 7151-7160 of 25037 for oral

  1. Coronary Artery Disease Clinical Trials - Mayo Clinic Research

    ... oral daily rapamycin (0.5, 1, and 2mg) dose for the duration of CR. Baseline and follow-up data will be collected for age-associated impairment (AAI): ...

  2. Publications - Sean C. Dowdy, M.D. - Mayo Clinic

    Direct oral anticoagulants (DOACs) for postoperative venous thromboembolism prophylaxis in patients with gynecologic malignancies: A quality mini-review.

  3. An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC. (PSMA-DC) - Mayo Clinic

    days before randomization. 7. Systemic (oral/i.v./Intramuscular (IM)) corticosteroids within 28 days before randomization. Note: Short term use (≤ 4 weeks) ...

  4. Neurologic Surgery Residency (Arizona) - Residencies and Fellowships - Mayo Clinic College of Medicine & Science

    Certification. Upon successful completion of the Neurologic Surgery Residency, residents will be eligible to take the oral board exam offered by The American ...

  5. Obstructive sleep apnea - Doctors and departments - Mayo Clinic

    Departments that treat this condition. Dental Specialties · Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Sleep ...

  6. Obstructive sleep apnea - Doctors and departments - Mayo Clinic

    Departments that treat this condition. Dental Specialties · Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Sleep ...

  7. Publications - Kevin T. Behm, M.D. - Mayo Clinic

    Oral Antibiotics Bowel Preparation Without Mechanical Preparation for Minimally Invasive Colorectal Surgeries: Current Practice and Future Prospects. Dis ...

  8. Hematology - Clinical trials

    Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral, target dose 400 mg) and will receive 6 cycles of rituximab infused intravenously (IV) ...

  9. Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer - Mayo Clinic

    Patients must be able to swallow and retain oral medications and without gastrointestinal illnesses that would preclude absorption of cediranib or olaparib ...

  10. Publications - William K. Freeman, M.D. - Mayo Clinic

    Long-Term Clinical Outcomes of Underdosed Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Atrial Flutter. Am J Med. 2021 Jun; 134(6):788 ...